Published in Transplant Proc on December 01, 1981
The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc Natl Acad Sci U S A (1996) 2.24
A genetic locus regulates the expression of tissue-specific mRNAs from multiple transcription units. Proc Natl Acad Sci U S A (1982) 1.10
Specificity of tumour associated transplantation antigens (TATA) of different clones from the same tumour. Br J Cancer (1984) 0.85
Tumour immunology: a review. J R Soc Med (1984) 0.80
A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung. Br J Cancer (1985) 0.75
The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell (2000) 8.95
The nuclear lamina is a meshwork of intermediate-type filaments. Nature (1986) 5.69
Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature (1997) 5.43
Determinants of HIV-1 shedding in the genital tract of women. Lancet (2001) 5.10
Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci U S A (1989) 5.03
Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature (1987) 4.59
HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell (1990) 4.50
Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell (1999) 4.38
HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J (1990) 3.92
Connections between cells of the developing squid as revealed by electrophysiological methods. Proc Natl Acad Sci U S A (1966) 3.59
A license to kill. Cell (1996) 3.37
Apoptosis in development. Nature (2000) 2.95
Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J (1985) 2.53
High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J Mol Biol (1993) 2.44
c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev (1999) 2.31
Distribution of saccharide residues on membrane fragments from a myeloma-cell homogenate: its implications for membrane biogenesis. Proc Natl Acad Sci U S A (1972) 2.29
Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene (1994) 2.05
A monoclonal anti-HLA antibody recognizes a mouse tumor-associated antigen. Eur J Immunol (1983) 1.97
Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clin Exp Immunol (1982) 1.97
Clinical testing of gliadin fractions in coeliac patients. Clin Sci (Lond) (1984) 1.93
Purification and characterization of nascent chains from immunoglobulin producing cells. Biochemistry (1973) 1.91
Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor. Biochem J (1986) 1.87
Differential expression of immediate early genes in the hippocampus and spinal cord. Neuron (1990) 1.76
A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression. J Mol Biol (1994) 1.67
Regulation of cell cycle duration by c-myc levels. Oncogene (1989) 1.67
The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis (1993) 1.62
Activation of human immunodeficiency virus transcription in T cells revisited: NF-kappaB p65 stimulates transcriptional elongation. J Virol (2001) 1.61
c-myc oncogene expression in colorectal cancer. Cancer (1987) 1.60
Phagocytic cells as effectors in a cell-mediated immunity system. J Immunol (1973) 1.56
Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team. AIDS (2000) 1.54
Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women. J Infect Dis (2001) 1.53
Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group. JAMA (1996) 1.47
Detection of the c-myc oncogene product in colonic polyps and carcinomas. Br J Cancer (1986) 1.47
A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding. AIDS (2001) 1.45
Hepatitis associated antigen (HAA) in pregnant women and their newborn infants. Am J Dis Child (1972) 1.45
Coagulase and deoxyribonuclease activities of staphylococci isolated from clinical sources. Appl Microbiol (1972) 1.40
Detection of the c-myc oncogene product in testicular cancer. Br J Cancer (1985) 1.40
Apoptosis regulators and their role in tumorigenesis. Biochim Biophys Acta (2001) 1.38
Photo-affinity labeling of specific acetylcholine-binding sites on membranes. Proc Natl Acad Sci U S A (1970) 1.38
Intracellular transport and secretion of an immunoglobulin light chain. Biochemistry (1971) 1.36
Lead and methyl mercury: effects of acute exposure on cytochrome P-450 and the mixed function oxidase system in the liver. J Exp Med (1972) 1.35
The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med (1993) 1.32
Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med (1995) 1.31
p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice. Curr Biol (1998) 1.31
Impact of sexual abuse on the HIV-risk-related behavior of adolescents in intensive psychiatric treatment. Am J Psychiatry (2000) 1.29
Raising antibodies by coupling peptides to PPD and immunizing BCG-sensitized animals. Ciba Found Symp (1986) 1.28
Subcellular fractionation of mouse myeloma cells. Biochemistry (1971) 1.27
Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis. Am J Med (1993) 1.24
Human immunodeficiency virus type 1 transactivator protein, tat, stimulates transcriptional read-through of distal terminator sequences in vitro. Proc Natl Acad Sci U S A (1993) 1.24
The induction and characterization of secretory IgA antibodies. Adv Exp Med Biol (1974) 1.24
Clinical testing of bread made from nullisomic 6A wheats in coeliac patients. Lancet (1980) 1.22
Ion channels in the nuclear envelope. Nature (1990) 1.22
Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate. J Biol Chem (2001) 1.19
A study of Chilean refugee children in Denmark. Lancet (1985) 1.19
Biosynthetic units of an immunoglobulin heavy chain. Proc Natl Acad Sci U S A (1967) 1.18
The human L-myc gene encodes multiple nuclear phosphoproteins from alternatively processed mRNAs. Mol Cell Biol (1988) 1.18
Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator. J Clin Invest (1997) 1.14
Cooperation and cell-mediated cytotoxicity as functions of two subsets of T cells. J Immunol (1974) 1.13
The secretory antibody response. Anti-DNP antibodies induced by dinitrophenylated type 3 pneumococcus. Immunol Commun (1974) 1.13
The impact of the ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal, and salivary compartments. J Interferon Cytokine Res (2000) 1.12
Hepatitis-associated antigen in pregnant women. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 1.12
A novel tumour marker related to the c-myc oncogene product. Mol Cell Probes (1987) 1.11
Translocation of a store of maternal cytoplasmic c-myc protein into nuclei during early development. Mol Cell Biol (1989) 1.10
Immunoglobulin nascent chains on membrane-bound ribosomes of myeloma cells. Biochemistry (1973) 1.10
Antigen-specific synergism in the immune response of irradiated mice given marrow cells and peritoneal cavity cells or extracts. J Exp Med (1970) 1.09
Expression of c-myc in non-malignant and pre-malignant gastrointestinal disorders. J Pathol (1987) 1.09
Bacteriophage neutralizing activity of fragments derived from rabbit immunoglobulin by papain digestion. J Immunol (1967) 1.08
Sleep disorders, sleepiness and traffic safety: a public health menace. Braz J Med Biol Res (2006) 1.08
Immunological studies in children before and after splenectomy. Acta Paediatr Scand (1976) 1.08
Human Bak induces cell death in Schizosaccharomyces pombe with morphological changes similar to those with apoptosis in mammalian cells. Mol Cell Biol (1997) 1.07
A carbohydrate-containing mouse light chain-protein. Biochem Biophys Res Commun (1966) 1.07
c-myc oncogene product expression and prognosis in operable breast cancer. Br J Cancer (1989) 1.06
Thrombocytopenia in childhood: an evaluation of 433 patients. Scand J Haematol (1976) 1.06
Transmission of hepatitis type B from healthy HBsAg-positive mothers. Br Med J (1976) 1.06
A radioimmunoassay for alpha- and beta-gliadins. Clin Sci (Lond) (1983) 1.04
Nuclear colocalization of cellular and viral myc proteins with HSP70 in myc-overexpressing cells. J Virol (1991) 1.03
Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge. Am J Respir Crit Care Med (1998) 1.03
A fusion protein formed by L-myc and a novel gene in SCLC. EMBO J (1991) 1.03
Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol (1994) 1.03
Multiple calcium-mediated effector mechanisms regulate chloride secretory responses in T84-cells. Am J Physiol (1989) 1.02
A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts. J Biol Chem (2000) 1.02
Complications of trochanteric osteotomy. Long-term implications. Clin Orthop Relat Res (1993) 1.02
The apoptosis endonuclease and its regulation. Semin Immunol (1992) 1.01
Localisation of metastatic carcinoma by a radiolabelled monoclonal antibody. Br J Cancer (1983) 0.98
Remote-site stimulation of secretory IgA antibodies following bronchial and gastric stimulation. Adv Exp Med Biol (1978) 0.97
A new monoclonal anti-A. Culture supernatants with the performance of hyperimmune human reagents. Vox Sang (1984) 0.96
The prediction of invasive potential in superficial transitional cell carcinoma of the bladder. Br J Urol (1982) 0.96
Specific TrkA survival signals interfere with different apoptotic pathways. Oncogene (1998) 0.96
Gene structure, cDNA sequence, and expression of murine Bak, a proapoptotic Bcl-2 family member. Genomics (1997) 0.95
Human blood group isoantigen expression on normal and malignant gastric epithelium studied with anti-A and anti-B monoclonal antibodies. J Natl Cancer Inst (1983) 0.95
Differing reactions of monoclonal anti-A antibodies with oligosaccharides related to blood group A. J Biol Chem (1985) 0.94
Immunohistochemical techniques in the early screening of monoclonal antibodies to human colonic epithelium. Br J Cancer (1982) 0.94
Thoracic reirradiation for symptomatic relief after prior radiotherapeutic management for lung cancer. Am J Clin Oncol (2000) 0.94
Betaine supplementation improves the atherogenic risk factor profile in a transgenic mouse model of hyperhomocysteinemia. Atherosclerosis (2007) 0.93
Sensitivity to myc-induced apoptosis is retained in spontaneous and transplanted lymphomas of CD2-mycER mice. Oncogene (2000) 0.93
Structural requirements of synthetic and natural product lipo-chitin oligosaccharides for induction of nodule primordia on Glycine soja. Plant Physiol (1995) 0.93
The control of transferrin receptor synthesis in mitogen-stimulated human lymphocytes. Exp Cell Res (1984) 0.93
H 9/25 monoclonal antibody recognizes a new allospecificity of mouse lymphocyte subpopulations: strain and tissue distribution. Eur J Immunol (1980) 0.92